Crescent Energy: Below Book Value, Above the Curve on Cash Flow

Crescent Energy trades at below book value with a forward P/E of 16. At the same time, the company is set to generate over $1 billion in levered free cash flow this year, with record production and rapidly captured synergies from a major Permian integration. The stock has climbed roughly 75% year-to-date, yet the valuation multiples look modest for an operator producing at that cash-flow rate.

The reason the numbers look contradictory is that Crescent's trailing P/E sits above 88 — an ugly number that makes the stock look overpriced at a glance. But the trailing multiple is inflated by one-time accounting effects from commodity derivatives and acquisition amortization, not by weak operations. Strip out those items and the underlying math tells a different story.

Why the Trailing Multiple Is Misleading

Crescent reported $494 million in GAAP net income for the second quarter of 2026. That sounds impressive, but it includes roughly $419 million in unrealized gains on commodity derivatives — non-cash accounting moves that don't represent cash the company can deploy. On an adjusted basis, net income for the quarter was $263 million, or $0.69 per share.

The reverse happened in prior periods. In the second quarter of 2025, GAAP net income was $153 million. In the first quarter of 2026, reported earnings per share were $0.53. Derivative accounting swings like this across periods, which is why the trailing twelve-month P/E of 88 looks disconnected from the forward P/E of 16. The forward estimate — $1.89 for full-year 2026 — reflects what analysts expect the company to earn once those swings normalize.

For investors who look at a P/E of 88 and walk away, the disconnect matters. The number doesn't reflect Crescent's actual cash-generating ability.

The Cash Flow Engine

Here's what Crescent is actually producing:

The company generated $418 million in levered free cash flow in Q2 alone, a quarterly record. Year-to-date through two quarters, free cash flow stands well above $600 million. Management expects the full-year total to exceed $1 billion at current commodity prices.

That cash flow comes from three converging forces. First, production surged to 335,000 barrels of oil equivalent per day in Q2, with 140,000 barrels of oil — well above the previous full-year guidance midpoint. Crescent raised its 2026 production outlook to 327,000–335,000 boe/d, pushing toward the top of its range. The company operates roughly 1.4 million net acres across the Permian, Eagle Ford, and Uinta basins, with year-end 2025 proved reserves of approximately 976 million boe.

Second, costs fell across every basin. Operating expenses in Q2 came in at $10.95 per boe, below the already-improved guidance range of $11–$12. Eagle Ford well costs are 25% below 2023 levels. Uinta development costs dropped nearly 20%, to below $800 per foot. Crescent tightened its full-year operating expense and production tax guidance in both cases.

Third, and most important, the Permian integration is generating synergies far above plan. When Crescent acquired the Permian assets, the company targeted $90–100 million in annualized synergies. That target has been raised to $250–300 million, roughly triple the original estimate. Approximately $190 million in annualized synergies have already been captured through lower well costs, reduced overhead, improved facility design, and better routing across 8,000 wells. Permian well costs are 20–25% below the prior operator's levels.

Management expects to capture most of the remaining synergy target by the end of 2026 and into 2027.

Minerals: Free Cash Flow Without a Drilling Budget

Most of the headlines focus on Crescent's working-interest production — the wells the company operates. But there's a quieter engine: the minerals and royalties portfolio.

Crescent owns royalty interests across approximately 122,000 net royalty acres, primarily concentrated in the Eagle Ford. These assets produce roughly 12,000 boe/d and are expected to generate approximately $200 million in EBITDA for 2026. The key feature is that these royalties are operated by blue-chip companies, meaning Crescent receives cash flow from production growth without spending a dollar of capital. It's a built-in tailwind that doesn't appear on any development spreadsheet.

The Balance Sheet Question

The heavy lifting on cash flow raises the natural question: where does it go?

Crescent carries $6.85 billion in total debt, with a net leverage ratio of 1.6x and a book value of $5.16 billion in equity. The company redeemed $259 million of 2029 senior notes in July, and previously used $714 million in asset-sale proceeds to pay down its revolving credit facility. The weighted average maturity of remaining debt is approximately six years, with $2.2 billion in liquidity.

The company's stated priority is rapid deleveraging toward investment-grade territory. The $1 billion-plus in expected 2026 free cash flow — minus operating needs, interest, taxes, and dividends — goes primarily to debt reduction. Share repurchases are described as opportunistic once deleveraging progress is "solidified."

The quarterly dividend remains $0.12 per share, yielding about 3.3%. The company increased its buyback authorization to $400 million in February 2026, but actual repurchases have been minimal so far.

Where the Valuation Lands

At $14.66 per share and a market capitalization of roughly $4.8 billion, Crescent trades at 16x forward 2026 EPS, below book value at 0.94x P/B, and at 6.6x EV/EBITDA on a trailing basis. For comparison, peers Ovintiv and Matador Resources trade at EV/EBITDA multiples of 10.1x and 4.9x, respectively. Crescent sits between them, but the company's trajectory — with production growing above 24% year-over-year and free cash flow expanding faster — leans toward the premium end of that range if execution holds.

The $1 billion in expected levered free cash flow for 2026, combined with a debt load of roughly $4.9 billion net, suggests meaningful deleveraging even before buybacks. If Permian synergies reach the higher end of the $250–300 million target, 2027 cash flow could expand further, even though management expects a slight production decline as the company resets Permian capital intensity and extends lateral lengths from two miles to three.

What Could Go Wrong

The thesis rests on execution. The Permian synergy target was raised three times over the original estimate, and not all of the captured synergies are fully annualized yet. The Q3 outlook hints at a near-term production dip — oil volumes are expected in the mid-130,000 bpd range — as the company transitions to longer laterals in the Permian. That's a timing issue, not a structural one, but it means the back half of 2026 won't be a straight line.

Commodity prices matter. The $1 billion free cash flow projection is stated "at current commodity prices." A sharp drop in crude would compress the entire model, though Crescent's oil-weighted mix (roughly 42% oil and 58% liquids combined) and significant Waha gas basis hedging at mid-$2 levels for the next 24 months provide some cushion.

The heavy debt load remains a risk in a downturn. At 1.6x leverage, there's room to operate, but the company is not yet at the investment-grade comfort level management targets.

The Bottom Line

Crescent Energy is not a stock that looks cheap because of a beaten-down price. The share price has climbed sharply this year. The case is simpler: the company is generating real cash flow at a rate that its forward multiples don't fully reflect, and the Permian integration is creating operational leverage that may continue to surprise.

The 16x forward P/E sits below the company's growth trajectory and below the premium peers command. If $1 billion in levered free cash flow materializes, deleveraging accelerates, and Permian synergies push toward the $300 million annualized target, the valuation gap narrows from both sides — cash flow expands and leverage falls.

At below book value, with 24% revenue growth and free cash flow margins in the high single digits, Crescent doesn't trade like the operator it's becoming. The question for investors is whether the math, which now supports the stock, will continue to improve fast enough to justify moving in.